A registry study of anterior nucleus of thalamus stimulation therapy for refractory epilepsy

JRCT ID: jRCT1052240157

Registered date:10/10/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: intractable focal epilepsy
• Date of first enrollment: 10/10/2024
• Target sample size: 200
• Study type: Observational

Outcome(s)

• Primary Outcome: seizure reducation rate, responder rate

Secondary Outcome

Medications
Developmental Status
Mental Status
Social Status
Quality of Life (QOLIE-31)
Memory (Rivermead Behavioral Memory Test)
Mood (Beck Depression Inventory II)
Adverse events, malfunctions

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable

Include criteria

Patients with refractory epilepsy who have undergone surgery after being judged as suitable for surgery by a physician who has attended the Deep Brain Stimulation (DBS) for Epilepsy Techniques Course held by the Japanese Epilepsy Society and is capable of judgment and adjustment of indications.
Patients who have given written consent to participate in the study.

• Exclude criteria: Persons deemed unsuitable by the principal investigator or principal investigator's assistant

Related Information

• Primary Sponsor: Kishima Haruhiko
• Source(s) of Monetary Support: Medtronic Japan Co., Ltd